Clinical pharmacokinetics of bambuterol

Bambuterol, a biscarbamate ester prodrug of the beta 2 adrenergic agonist terbutaline, has been approved for the treatment of asthma in 28 countries. It is available in 10 and 20mg (25 and 50 mumol) tablets as the hydrochloride salt. Bambuterol is stable to presystemic elimination and is concentrate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical pharmacokinetics 1996-10, Vol.31 (4), p.246-256
1. Verfasser:	SITAR, D. S
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Asthma - drug therapy Biological and medical sciences Bronchodilator Agents - metabolism Bronchodilator Agents - pharmacokinetics Bronchodilator Agents - therapeutic use Humans Medical sciences Pharmacology. Drug treatments Prodrugs - metabolism Prodrugs - pharmacokinetics Prodrugs - therapeutic use Respiratory system Terbutaline - analogs & derivatives Terbutaline - metabolism Terbutaline - pharmacokinetics Terbutaline - therapeutic use Tissue Distribution
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!